Previous 10 | Next 10 |
SAN JOSE, Calif. , June 1, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced that the Company, together with partner OntoChem GmbH, has synthesized f...
Hertz Global Holdings (NYSE: HTZ ) -16% after it enters into forbearances and limited waivers . More news on: Hertz Global Holdings, Inc., Centennial Resource Development, Inc., Compass Diversified Holdings LLC, Stocks on the move, , Read more ...
Stemline Therapeutics (NASDAQ: STML ) +151% on Menarini bid . More news on: Stemline Therapeutics, Inc., Applied DNA Sciences, Inc., KLX Energy Services Holdings, Inc., Stocks on the move, , Read more ...
Anixa Biosciences (NASDAQ: ANIX ), together with partner OntoChem GmbH, has identified its first therapeutic candidate against COVID-19 and has advanced the compound into biological testing. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read ...
SAN JOSE, Calif. , May 4, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced that it, with partner OntoChem GmbH, has identified its first therap...
SAN JOSE, Calif. , April 23, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced the publication of a peer-reviewed journal article in Biomarker ...
Thinly traded nano cap Anixa Biosciences (NASDAQ: ANIX ), a developer of cancer therapies, has agreed to collaborate with OntoChem GmbH to discover and develop antiviral candidates for the potential treatment of COVID-19. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Sto...
SAN JOSE, Calif. , April 20, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced that it has entered into a strategic collaboration with OntoChem ...
SAN JOSE, Calif. , Feb. 12, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that the research team lead by Dr. Jose Conejo-Garcia , Chair of the Departm...
Home DNA testing services provider 23andMe ( DNA ) plans to terminate 100 people, 14% of its workforce, in response to weakening sales. Most of the cuts will affect operations teams that were focused on growth and scaling efforts. More news on: 23andMe, Anixa Biosciences, Inc., Guardant ...
News, Short Squeeze, Breakout and More Instantly...
Anixa Biosciences Inc. Company Name:
ANIX Stock Symbol:
NASDAQ Market:
Anixa Biosciences Inc. Website:
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology PR Newswire SAN JOSE, Calif. , July 17, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment an...
Anixa Biosciences Announces $5 Million Share Repurchase Program PR Newswire SAN JOSE, Calif. , July 15, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of ...
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial PR Newswire This patient is expected to be the final patient in the second dosage cohort of the trial SAN JOSE, Calif. , June 24, 2024 /PRNewswire/ -- Anixa Biosciences, I...